PPH - VanEck Vectors Pharmaceutical ETF
|Ex-Dividend Date||Apr 1, 2021|
|Trading Day||April 20|
|Day's Range||69.26 - 69.67|
|52-Week Range||57.05 - 70.79|
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
|Asset Class |
|Inception Date |
Feb 1, 2000
|Ticker Symbol |
|Index Tracked |
MVIS US Listed Pharmaceutical 25 Index
Top 10 Holdings51.37% of assets
|Novartis AG ADR||NVSN.MX||5.17%|
|Johnson & Johnson||JNJ||5.03%|
|Novo Nordisk A/S||NVO||4.99%|
|Apr 1, 2021||$0.3497||Apr 8, 2021|
|Dec 29, 2020||$0.266||Jan 5, 2021|
|Oct 1, 2020||$0.249||Oct 7, 2020|
|Jul 1, 2020||$0.252||Jul 8, 2020|
|Apr 1, 2020||$0.3374||Apr 7, 2020|
|Dec 30, 2019||$0.1729||Jan 6, 2020|
Pharmaceutical stocks gained a lot from the pandemic and the race to vaccines, but most of that upside is off the table now. The post 7 Pharmaceutical Stocks That Could Get a Covid Hangover appeared fir...
Coming off a vaccine rally that started in the middle of 2020, the pharmaceutical industry will continue to evolve as technological advances make their way into the sector, which should help ETFs like t...
Sector ETF report for PPH
With 2020 election season in the rearview mirror, it could be a great time to revisit health and pharmaceutical ETFs, including the VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH). PPH tracks the MVIS U...
After scuffling amid political uncertainty leading up to Election Day, pharmaceutical stocks and exchange-traded funds are finally perking amid a spate of encouraging news regarding coronavirus vaccine ...
By VanEck Hope Springs Eternal Hopes of a return to normality are increasing after a year of pandemic-induced tumult. News that COVID-19 vaccines developed by Pfizer and BioNTech, and Moderna were more ...
Investors looking for compelling valuations don’t have to go deep into the lagging value factor. They can harness some growth with pharmaceuticals ETFs, including the VanEck Vectors Pharmaceutical ETF (...
The VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH) is among the healthcare ETFs recently showing signs of life due in large part to the fight against the coronavirus and although this is an election ye...
With Economic Impact Payments beginning to arrive, it's time to put your money to work.
The pharmaceutical industry is often a hotbed of takeover rumors.
Given recovering fundamentals, investors should take advantage of the beaten-down prices. For them, we have highlighted four solid ETF & stock picks each from the industries that are currently undervalu...
Robust results led to solid trading in pharma ETFs in a month.
Pharmaceuticals stocks and ETFs, including the VanEck Vectors Pharmaceutical ETF (NASDAQ: PPH), rallied Friday after Senate Majority Leader Mitch McConnell (R-KY) said a House effort to lower drug price...
Despite robust results, pharma ETFs have been trending downward in a month.